Lawrence, KS, United States of America

Mary Lou Michaelis

This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Lou Michaelis. Retrieved from https://idiyas.com/inventor/mary-lou-michaelis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Lou Michaelis: Innovator in Neuroprotective Agents

Introduction

Mary Lou Michaelis is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of neuroprotective agents, particularly through her innovative research and development of pharmaceutical compositions.

Latest Patents

Mary Lou Michaelis holds a patent for "Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders." This patent focuses on novobiocin analogues and pharmaceutical compositions containing such compounds that are useful for the treatment and/or prevention of neurodegenerative disorders and autoimmune disorders. She has 1 patent to her name.

Career Highlights

Mary Lou Michaelis is affiliated with the University of Kansas, where she conducts her research. Her work has been instrumental in advancing the understanding of neuroprotective agents and their potential applications in treating various disorders.

Collaborations

She has collaborated with notable colleagues, including Brian Blagg and Michelle McIntosh, to further her research initiatives.

Conclusion

Mary Lou Michaelis is a dedicated inventor whose work in neuroprotective agents has the potential to impact the treatment of neurodegenerative and autoimmune disorders significantly. Her contributions to the field are noteworthy and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…